会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • BINDING DOMAINS
    • 绑定域
    • WO1992001787A1
    • 1992-02-06
    • PCT/GB1991001253
    • 1991-07-25
    • CAMBRIDGE ANTIBODY TECHNOLOGY LIMITEDJOHNSON, Kevin, StuartJACKSON, Ronald, HenryCHISWELL, David, John
    • CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
    • C12N15/12
    • C07K16/00A61K38/00C07K14/705
    • This invention concerns binding domains e.g. single chain variable domains which are synthetic analogues of other single chain variable domains of members of an immunoglobulin family or superfamily. In the analogue, one or more amino acid residues is altered as compared to the other domain, so that the analogue is more hydrophilic than the natural domain. The altered amino acid is substituted with a residue which occurs in an analogous position in a member of an immunoglobulin family or superfamily. This increased hydrophilicity means that the synthetic analogue will show less non-specific binding than the natural domain. The analogue may retain the binding specificity of the natural domain. Alternatively, the complementarity determining regions may be altered to change the binding specificity. The invention also concerns methods for making these binding domains.
    • 本发明涉及结合域,例如 单链可变结构域,其是免疫球蛋白家族成员或超家族的其它单链可变结构域的合成类似物。 在类似物中,与其他结构域相比,一个或多个氨基酸残基被改变,使得类似物比天然结构域更亲水。 改变的氨基酸被以在免疫球蛋白家族成员或超家族中的类似位置发生的残基取代。 这种增加的亲水性意味着合成类似物将显示比天然结构域更少的非特异性结合。 类似物可以保留天然结构域的结合特异性。 或者,可以改变互补决定区以改变结合特异性。 本发明还涉及制备这些结合结构域的方法。
    • 9. 发明申请
    • LABELLING AND SELECTION OF MOLECULES
    • 标签和选择分子
    • WO1998001757A1
    • 1998-01-15
    • PCT/GB1997001835
    • 1997-07-08
    • CAMBRIDGE ANTIBODY TECHNOLOGY LIMITEDOSBOURN, Jane, KatharineDERBYSHIRE, Elaine, JoyMcCAFFERTY, John, GeraldVAUGHAN, Tristan, JohnJOHNSON, Kevin, Stuart
    • CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
    • G01N33/535
    • G01N33/532A61K38/00C07K1/36C07K14/523C07K14/70542C07K14/70596C07K14/82C07K16/00C07K16/065C07K16/22C07K16/2854C07K16/2866C07K16/2896C07K16/3007C07K16/32C07K16/4266C07K2317/34C07K2317/622C12N9/16G01N33/535
    • A method of labelling molecules which includes providing in a common medium a label molecule, a marker ligand able to bind a member of a specific binding pair, such as an antigen, a sbp member, an enzyme able to catalyse binding of the label molecule to other molecules, the enzyme being associated with the marker ligand; causing or allowing binding of the marker ligand to the sbp member; and causing or allowing binding of the label molecule to other molecules in the vicinity of the marker ligand bound to the sbp member. The marker ligand may be an antibody or any specific binding molecule, such as a chemokine or cytokine. A complementary member of the specific binding pair may be included, e.g. an antibody, or a diverse population of such sbp members, e.g. antibodies, may be included within which those which bind the counterpart sbp member, e.g. antigen, may be labelled and subsequently isolated for manipulation and/or use. Suitable labels include biotin-tyramine with signal transfer being catalysed by hydrogen peroxidase. Cells, virus particles and other moieties may be labelled, for identification or obtention of proteins which interact or are in close proximity with a particular sbp member, or of cells of interest, or for enhancement of labelling, e.g. for cell sorting.
    • 标记分子的方法,其包括在普通培养基中提供标记分子,能够结合特异性结合对成员的标记配体,例如抗原,sbp成员,能够催化标记分子结合的酶 其他分子,酶与标记配体相关; 引起或允许标记配体与sbp构件的结合; 并引起或允许标记分子与结合于sbp构件的标记配体附近的其它分子结合。 标记物配体可以是抗体或任何特异性结合分子,例如趋化因子或细胞因子。 可以包括特异性结合对的互补成员,例如。 抗体,或这样的sbp成员的不同群体,例如。 可以包括其中结合对应物sbp成员的那些抗体。 抗原,可以被标记并随后分离用于操作和/或使用。 合适的标记包括具有由过氧化氢酶催化的信号传递的生物素 - 酪胺。 可以标记细胞,病毒颗粒和其它部分,用于鉴定或获得与特定sbp成员或感兴趣的细胞相互作用或紧密接近的蛋白质,或用于增强标记,例如, 用于细胞分选。